Search - tctmd.com

Displaying 41 - 60 of 249

Sort: Relevancy | Date

No Big Jumps in Smartwatch Accuracy for AF Detection Over Time

News Daily News

No Big Jumps in Smartwatch Accuracy for AF Detection Over Time

November 20, 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

November 18, 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

November 18, 2024

Presentation AHA 2024

Comparison of Linear Ablation Plus Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone for Persistent Atrial Fibrillation

Presenter: Chenyang Jiang

November 18, 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

November 16, 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

News Conference News AHA 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

November 16, 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presentation AHA 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presenter: John Sapp

November 16, 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

November 14, 2024

FDA Approves Varipulse Pulsed-Field Ablation System for AF

News Daily News

FDA Approves Varipulse Pulsed-Field Ablation System for AF

Michael O'Riordan

November 07, 2024

FDA Approves Dual-Energy System for AF Ablation

News Daily News

FDA Approves Dual-Energy System for AF Ablation

October 28, 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

October 27, 2024

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

TCTMD’s Top 10 Most Popular Stories for September 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

October 01, 2024

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

September 30, 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

News Conference News ESC 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

September 06, 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

News Conference News ESC 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

September 06, 2024

SHAM-PVI Catheter Ablation Improves Objective Measure of AF Burden

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

September 02, 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presentation ESC 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presenter: Rick Veasey

September 02, 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presentation ESC 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presenter: Masaharu Masuda

September 02, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.